Avenue Therapeutics, Inc.

Ownership Transactions Reported by 12 Insiders

Symbol
ATXI on Nasdaq
Industry
Pharmaceutical Preparations
Location
1111 Kane Concourse, Suite 301, Bay Harbor Islands, FL

Insiders trading volume in the past year

Avenue Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fortress Biotech, Inc. 10%+ Owner $497K Apr 16, 2024
Robert Davidow 10%+ Owner $171K -$86.6K -33.6% Dec 11, 2023
Lucy Lu President, CEO, Director $105K Dec 17, 2021
Lindsay A. Md Rosenwald Director $49.6K Sep 8, 2023
Joseph Vazzano Chief Financial Officer $23.2K Dec 17, 2021
Faith L. Charles Director Jun 30, 2023
Alexandra MacLean Chief Executive Officer, Director Jun 29, 2023
InvaGen Pharmaceuticals, Inc. 10%+ Owner Oct 11, 2022
David Jin Interim PFO and COO Jun 30, 2023
Jay D. Kranzler Director Jun 30, 2023
Neil Herskowitz Director Jun 30, 2023
Curtis Gale Oltmans Director Jun 30, 2023

Recent Insider Transactions by Companies or Individuals for Avenue Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.